Long‐Term Effects of Nusinersen Dosing Frequency on Adult Patients With Spinal Muscular Atrophy: Efficacy of a 6‐Month Dosing Interval

Long‐Term Effects of Nusinersen Dosing Frequency on Adult Patients With Spinal Muscular Atrophy: Efficacy of a 6‐Month Dosing Interval

ABSTRACT Objective Spinal muscular atrophy (SMA) is a genetic disease caused by the degeneration of spinal motor neurons due to a deficiency in survival motor neuron protein (SMN) protein, leading to progressive muscle atrophy and weakness. nusinersen, an antisense oligonucleotide that increases SMN...

Full description

Saved in:
Bibliographic Details
Main Authors: Keita Takahashi, Hitaru Kishida, Misako Kunii, Yosuke Miyaji, Yuichi Higashiyama, Hiroshi Doi, Naohisa Ueda, Hideyuki Takeuchi, Fumiaki Tanaka
Format: Article
Language:English
Published: Wiley 2025-05-01
Series:Brain and Behavior
Subjects:
adult patient
long‐term efficacy
nusinersen
spinal muscular atrophy (SMA)
survival motor neuron protein (SMN)
Online Access:https://doi.org/10.1002/brb3.70528
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items